
|Articles|January 29, 2008
Clot-dissolving agent gains additional shelf life
ImaRx Therapeutics' urokinase gains an additional 20 months of expiration dating
Advertisement
ImaRx Therapeutics' urokinase has received an additional 20 months of expiration dating. This means the clot buster from the Tucson, Ariz., firm's most recent lot will have a prolonged shelf life. The thombolytic is indicated for the treatment of acute massive pulmonary embolism.
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
4
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
5






























